Angiola Rocino

3.9k total citations
87 papers, 2.9k citations indexed

About

Angiola Rocino is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Angiola Rocino has authored 87 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Hematology, 20 papers in Genetics and 10 papers in Molecular Biology. Recurrent topics in Angiola Rocino's work include Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (19 papers). Angiola Rocino is often cited by papers focused on Hemophilia Treatment and Research (76 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (19 papers). Angiola Rocino collaborates with scholars based in Italy, Spain and Sweden. Angiola Rocino's co-authors include Elena Santagostino, Pier Mannuccio Mannucci, Massimo Morfini, Maria Elisa Mancuso, Antonio Coppola, A. Gringeri, Annarita Tagliaferri, Giancarlo Castaman, F. A. Scaraggi and R. De Biasi and has published in prestigious journals such as New England Journal of Medicine, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Angiola Rocino

83 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angiola Rocino Italy 35 2.5k 653 393 203 195 87 2.9k
Katsuyuki Fukutake Japan 19 1.5k 0.6× 443 0.7× 213 0.5× 40 0.2× 66 0.3× 139 1.9k
Günter Auerswald Germany 22 1.5k 0.6× 316 0.5× 160 0.4× 50 0.2× 52 0.3× 46 1.6k
Isabel Badell Spain 24 806 0.3× 279 0.4× 234 0.6× 55 0.3× 255 1.3× 108 1.6k
Lorentz Brinch Norway 21 1.0k 0.4× 233 0.4× 327 0.8× 48 0.2× 338 1.7× 61 1.7k
G. R. Buchanan United States 13 482 0.2× 174 0.3× 336 0.9× 202 1.0× 206 1.1× 22 1.2k
Michael Steinbuch United States 14 613 0.2× 212 0.3× 187 0.5× 28 0.1× 130 0.7× 24 1.3k
Mallika Sekhar United Kingdom 16 286 0.1× 327 0.5× 178 0.5× 83 0.4× 88 0.5× 39 705
Payal Desai United States 14 497 0.2× 601 0.9× 106 0.3× 50 0.2× 78 0.4× 74 909
Carrie L. Kitko United States 24 1.6k 0.6× 283 0.4× 152 0.4× 18 0.1× 111 0.6× 94 2.1k
Roberta Ghilardi Italy 7 965 0.4× 1.1k 1.7× 63 0.2× 22 0.1× 77 0.4× 10 1.3k

Countries citing papers authored by Angiola Rocino

Since Specialization
Citations

This map shows the geographic impact of Angiola Rocino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angiola Rocino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angiola Rocino more than expected).

Fields of papers citing papers by Angiola Rocino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angiola Rocino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angiola Rocino. The network helps show where Angiola Rocino may publish in the future.

Co-authorship network of co-authors of Angiola Rocino

This figure shows the co-authorship network connecting the top 25 collaborators of Angiola Rocino. A scholar is included among the top collaborators of Angiola Rocino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angiola Rocino. Angiola Rocino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fornari, Arianna, Ippazio Cosimo Antonazzo, Angiola Rocino, et al.. (2023). The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey. Haemophilia. 30(2). 449–462. 3 indexed citations
3.
Coppola, Antonio, Massimo Franchini, Armando Tripodi, et al.. (2022). Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding.. PubMed. 20(3). 245–262. 14 indexed citations
4.
Biasoli, Chiara, Erminia Baldacci, Antonio Coppola, et al.. (2022). Promoting physical activity in people with haemophilia: the MEMO (Movement for persons with haEMOphilia) expert consensus project. Nova Science Publishers (Nova Science Publishers, Inc.). 9 indexed citations
5.
Borchiellini, Alessandra, Giancarlo Castaman, G. Peter Feola, et al.. (2021). Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians. Journal of Thrombosis and Thrombolysis. 53(4). 934–944. 2 indexed citations
6.
Minno, Giovanni Di, Antonio Coppola, Maurizio Margaglione, et al.. (2021). Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors. Haemophilia. 28(1). 55–64. 10 indexed citations
7.
Minno, Matteo Nicola Dario Di, Mariasanta Napolitano, Erminia Baldacci, et al.. (2021). Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres. British Journal of Haematology. 196(4). 871–883. 17 indexed citations
8.
9.
Zanon, Ezio, Samantha Pasca, Elena Santagostino, et al.. (2019). Immune tolerance induction with moroctocog‐alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high‐titre inhibitors: Data from REF.IT Registry. Haemophilia. 25(6). 1003–1010. 2 indexed citations
10.
11.
Mackensen, Sylvia von, Silvia Riva, Kate Khair, et al.. (2013). Development of an inhibitor-specific questionnaire for the assessment of health-related quality of life in haemophilia patients with inhibitors (INHIB-QoL). Value in Health. 16(3). A196–A196. 4 indexed citations
12.
Mancuso, Maria Elisa, Pier Mannuccio Mannucci, Angiola Rocino, et al.. (2012). Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A. Journal of Thrombosis and Haemostasis. 10(5). 781–790. 40 indexed citations
13.
Fusco, Francesca, L Scalone, Angiola Rocino, et al.. (2011). Cost of Immune Tolerance Induction in Hemophilia A Patients: Results from the ITER Study. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 2005(26). nf52–nf52. 1 indexed citations
14.
Moerloose, Philippe de, Kathelijn Fischer, Thierry Lambert, et al.. (2011). Recommendations for assessment, monitoring and follow‐up of patients with haemophilia. Haemophilia. 18(3). 319–325. 47 indexed citations
15.
Santagostino, Elena, G. Auerswald, Víctor Jiménez‐Yuste, et al.. (2010). European Initiative to prevent joint damage in haemophilia children with inhibitors (ENJOIH) - a prospective study. Haemophilia. 16(2). 407–407. 7 indexed citations
16.
Tagliaferri, Annarita, G Rivolta, Alfonso Iorio, et al.. (2010). Mortality and causes of death in Italian persons with haemophilia, 1990–2007. Haemophilia. 16(3). 437–446. 136 indexed citations
17.
Sanna, Veronica, Federica Zarrilli, Valeria D’Argenio, et al.. (2008). Mutational spectrum of F8 gene and prothrombotic gene variants in haemophilia A patients from Southern Italy. Haemophilia. 14(4). 796–803. 9 indexed citations
18.
Santagostino, Elena, et al.. (2006). A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. Thrombosis and Haemostasis. 4. 367–371. 10 indexed citations
19.
Astermark, Jan, Angiola Rocino, Mario von Depka, et al.. (2006). Current use of by‐passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors. Haemophilia. 13(1). 38–45. 43 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyuki Fukutake Breakdown of academic impact, for papers by Günter Auerswald Breakdown of academic impact, for papers by Isabel Badell Breakdown of academic impact, for papers by Lorentz Brinch Breakdown of academic impact, for papers by G. R. Buchanan Breakdown of academic impact, for papers by Michael Steinbuch Breakdown of academic impact, for papers by Mallika Sekhar Breakdown of academic impact, for papers by Payal Desai Breakdown of academic impact, for papers by Carrie L. Kitko Breakdown of academic impact, for papers by Roberta Ghilardi
Rankless by CCL
2026